Functional phenotyping of the CYP2D6 probe drug codeine in the horse.
Authors: Gretler S R, Finno C J, Kass P H, Knych H K
Journal: BMC veterinary research
Summary
# Editorial Summary: CYP2D6 Metabolic Phenotyping in Horses Genetic variation in drug-metabolising enzymes significantly influences therapeutic efficacy and safety, yet little is known about cytochrome P450 polymorphisms in horses. Gretler and colleagues administered codeine to a large equine population and measured plasma metabolite ratios (MR) to classify horses as extensive, intermediate, or poor metabolisers of this CYP2D82 substrate. The study demonstrated considerable inter-individual variation in codeine metabolism across the population, suggesting the presence of functional genetic polymorphisms in the equine CYP2D82 enzyme. Since codeine is a probe drug—a standard marker for P450 activity used extensively in human pharmacogenetics—these findings imply that similar metabolic variation likely affects other therapeutics dependent on this pathway, including certain opioids and antimicrobials commonly used in equine practice. Future genotyping studies linking metaboliser phenotypes to CYP2D82 variants could facilitate personalised dosing protocols, potentially improving clinical outcomes and reducing adverse drug reactions in horses receiving CYP2D82-dependent medications.
Read the full abstract on PubMed
Practical Takeaways
- •Individual horses may metabolize drugs differently due to genetic variation in CYP2D82 — consider that standard drug doses may have variable effects across your herd
- •Codeine or similar probe substrates could potentially be used to identify which horses are fast or slow drug metabolizers, allowing personalized dosing strategies
- •Further research is needed to establish practical testing protocols and determine which common therapeutic drugs are affected by these polymorphisms
Key Findings
- •Codeine administration and plasma analysis successfully classified horses into distinct metabolic phenotypes
- •Significant variation in codeine metabolism rates observed across the horse population suggests underlying genetic polymorphisms in CYP2D82
- •CYP2D82 genetic polymorphisms likely affect metabolism of therapeutic drugs in horses